Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

383
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
383
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

122
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
122
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect01:28

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

194
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly...
194
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

160
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
160
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.9K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potassium Imbalance in Patients with Hypertension and Acute Haemorrhagic Stroke in a Tertiary Level Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2026
Same author

Effect of Nd: YAG Laser Capsulotomy Size on Visual Acuity and Posterior Segment Outcomes: A 6-Months Follow-Up Study.

Mymensingh medical journal : MMJ·2026
Same author

Effect of Intraoperative Infiltration of Local Anaesthetic Agent on Post-tonsillectomy Pain.

Mymensingh medical journal : MMJ·2025
Same author

Impact of Adenotonsillectomy in Children Suffering From Recurrent Upper Respiratory Tract Infections.

Mymensingh medical journal : MMJ·2025
Same author

Adverse Events Following Sinopharm Covid-19 Vaccination among Medical Students.

Mymensingh medical journal : MMJ·2025
Same author

Knowledge, Attitude and Practice about Covid-19 among the Adult Population of a Sub-urban Community in Bangladesh.

Mymensingh medical journal : MMJ·2025
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.0K

Dose-time-response modeling using negative binomial distribution.

Munmun Roy1, Kanak Choudhury, M M Islam

  • 1a Statistics Department, Head Office, Bangladesh Bank , Dhaka , Bangladesh.

Journal of Biopharmaceutical Statistics
|October 22, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a new dose-time-response model using the negative binomial distribution to analyze drug effectiveness over time and at various dosage levels, crucial for epidemiological research.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K

Related Experiment Videos

Last Updated: May 6, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.3K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Pharmacometrics

Background:

  • Determining safe and effective drug dosage is critical for treating diseases.
  • Epidemiological studies often involve observing cure rates across different drug dose levels.
  • Overdispersed count data in such studies can be modeled using the negative binomial distribution.

Purpose of the Study:

  • To investigate the combined effect of drug dosage and time on treatment response.
  • To develop a statistical model that accounts for both dose and time in epidemiological studies.
  • To provide methods for estimating effective dose and time parameters.

Main Methods:

  • Proposed a novel dose-time-response model incorporating the negative binomial distribution.
  • Formulated closed-form point estimation and confidence bands for key parameters like ED(100p)(t) and LT(100p)(d).
  • Utilized numerical illustrations to evaluate the model's performance.

Main Results:

  • The developed model effectively integrates dose and time effects on drug response.
  • Closed-form solutions for estimation and confidence bands were successfully derived.
  • Numerical analyses confirmed the model's applicability and performance.

Conclusions:

  • The proposed dose-time-response model offers a robust framework for analyzing drug efficacy in epidemiological contexts.
  • The model provides valuable tools for estimating effective drug doses and treatment durations.
  • This approach enhances the understanding of drug-disease interactions over time and varying dosages.